Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali
Clinical trial NCT03510481 · COMPLETED
Trial details
- NCT number
- NCT03510481
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-14
- Primary completion
- 2019-11-23
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.